HomeCompareSBMFF vs EPRT

SBMFF vs EPRT: Dividend Comparison 2026

SBMFF yields 1.32% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPRT wins by $34.6K in total portfolio value
10 years
SBMFF
SBMFF
● Live price
1.32%
Share price
$0.76
Annual div
$0.01
5Y div CAGR
27.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.8K
Annual income
$2,017.55
Full SBMFF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — SBMFF vs EPRT

📍 EPRT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBMFFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBMFF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBMFF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBMFF
Annual income on $10K today (after 15% tax)
$111.99/yr
After 10yr DRIP, annual income (after tax)
$1,714.92/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EPRT beats the other by $9,199.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBMFF + EPRT for your $10,000?

SBMFF: 50%EPRT: 50%
100% EPRT50/50100% SBMFF
Portfolio after 10yr
$46.1K
Annual income
$7,429.14/yr
Blended yield
16.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SBMFF
No analyst data
Altman Z
3.2
Piotroski
7/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBMFF buys
0
EPRT buys
0
No recent congressional trades found for SBMFF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBMFFEPRT
Forward yield1.32%3.92%
Annual dividend / share$0.01$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR27.4%29%
Portfolio after 10y$28.8K$63.4K
Annual income after 10y$2,017.55$12,840.73
Total dividends collected$7.6K$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SBMFF vs EPRT ($10,000, DRIP)

YearSBMFF PortfolioSBMFF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$10,868$167.85$11,205$505.18$337.00EPRT
2$11,846$217.20$12,672$682.46$826.00EPRT
3$12,957$281.88$14,490$930.48$1.5KEPRT
4$14,231$367.10$16,786$1,282.69$2.6KEPRT
5$15,707$480.07$19,753$1,791.56$4.0KEPRT
6$17,438$630.89$23,677$2,541.64$6.2KEPRT
7$19,492$833.93$29,008$3,672.99$9.5KEPRT
8$21,967$1,109.91$36,463$5,425.08$14.5KEPRT
9$24,993$1,489.27$47,238$8,221.57$22.2KEPRT
10$28,761$2,017.55$63,385$12,840.73$34.6KEPRT

SBMFF vs EPRT: Complete Analysis 2026

SBMFFStock

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Full SBMFF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this SBMFF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBMFF vs SCHDSBMFF vs JEPISBMFF vs OSBMFF vs KOSBMFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.